|
2024
|
Invention
|
Cancer treatments.
A pharmaceutical combination comprising (i) a replicative oncolytic vaccinia ... |
|
2023
|
Invention
|
Novel use of oncolytic virus. The present invention relates to novel use of an oncolytic virus, a... |
|
|
P/S
|
Oncolytic viruses being biopharmaceutical agents for the prevention, diagnosis, and treatment of ... |
|
|
Invention
|
Pharmaceutical combinations for use in the treatment of neoplastic diseases.
The present inventi... |
|
|
Invention
|
Pharmaceutical combinations for use in the treatment of neoplastic diseases. The present inventio... |
|
2022
|
Invention
|
Methods of treating neoplastic diseases.
The invention provides a compound of formula (I) or a p... |
|
|
Invention
|
Pharmaceutical compositions comprising modified betacyclodextrins.
The present invention relates... |
|
|
Invention
|
Pharmaceutical compositions comprising modified beta-cyclodextrins. The present invention relates... |
|
|
Invention
|
Methods of treating neoplastic diseases. The invention provides a compound of formula (I) or a ph... |
|
|
Invention
|
Oncolytic virus simultaneously expressing cd55 and cd59. The present invention relates to an onco... |
|
|
Invention
|
Oncolytic virus and uses thereof.
The present invention relates to an oncolytic virus and the us... |
|
|
Invention
|
Oncolytic virus and use thereof. The present invention relates to an oncolytic virus and a use th... |
|
|
Invention
|
Oncolytic virus and uses thereof. The present invention relates to an oncolytic virus and a use t... |
|
2021
|
Invention
|
Prognostic biomarkers for ttk inhibitor chemotherapy. A method for identifying a tumor that is su... |
|
|
P/S
|
Pharmaceutical products and drug delivery platforms in the nature of compounds that facilitate de... |
|
|
P/S
|
Pharmaceutical products, drug discovery and drug delivery
platforms for the prevention, diagnosi... |
|
2020
|
Invention
|
Immune assay for monitoring response to oncolytic vaccinia virus and uses thereof.
Provided here... |
|
|
Invention
|
Immune assay for monitoring response to oncolytic vaccinia virus and uses thereof. Provided herei... |
|
2019
|
P/S
|
Biopharmaceutical agents in the form of oncolytic viruses for the prevention, diagnosis, and trea... |
|
|
Invention
|
Oncolytic vaccinia virus expressing an immune checkpoint protein antagonist to treat cancer. The ... |
|
2018
|
Invention
|
Oncolytic vaccinia virus and checkpoint inhibitor combination therapy.
A pharmaceutical combinat... |
|
|
Invention
|
Oncolytic vaccinia virus and checkpoint inhibitor combination therapy. A pharmaceutical combinati... |
|
|
Invention
|
Generation of antibodies to tumor antigens and generation of tumor specific complement dependent ... |
|
|
Invention
|
Injection composition containing acetaminophen. The present disclosure relates to the injection c... |
|
2016
|
Invention
|
(5,6-dihydro)pyrimido[4,5-e]indolizines. A compound of Formula I:
2 independently are selected f... |
|
|
Invention
|
Modified oncolytic vaccinia viruses expressing a cytokine and a car-boxylesterase and methods of ... |
|
|
Invention
|
Modified oncolytic vaccinia viruses expressing a cytokine and a car- boxylesterase and methods of... |
|
|
Invention
|
Modified oncolytic vaccinia viruses expressing a cytokine and a carboxylesterase and methods of u... |
|
|
Invention
|
Compositions and methods for viral embolization. The present disclosure relates to oncolytic viru... |
